GI Innovation

GI Innovation EBIT

The EBIT of GI Innovation (358570.KQ) as of Oct 27, 2026 is -40.51 B KRW. In the previous year, EBIT was -48.26 B KRW — a change of -16.07% (higher).

EBIT

-40.51 BKRW

YoY

-16.07%

Last updated:

In 2025, GI Innovation's EBIT was -40.51 B KRW, a -16.07% increase from the -48.26 B KRW EBIT recorded in the previous year.

The GI Innovation EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2020
-22.87 B KRW
Jan 1, 2021
-32.09 B KRW
Jan 1, 2022
-67.95 B KRW
Jan 1, 2023
-53.30 B KRW
Jan 1, 2024
-48.26 B KRW
Jan 1, 2025
-40.51 B KRW
Jan 1, 2026 (e)
-5.05 B KRW
The GI Innovation EBIT history
YEAREBITYoY
est-5.05 BKRW-87.53%
-40.51 BKRW-16.07%
-48.26 BKRW-9.46%
-53.30 BKRW-21.56%
-67.95 BKRW+111.75%
-32.09 BKRW+40.29%
-22.87 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

GI Innovation Revenue

GI Innovation Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
11.02 B KRW
-22.87 B KRW
-75.93 B KRW
Jan 1, 2021
5.60 B KRW
-32.09 B KRW
-150.74 B KRW
Jan 1, 2022
3.50 B KRW
-67.95 B KRW
-79.83 B KRW
Jan 1, 2023
5.32 B KRW
-53.30 B KRW
-55.50 B KRW
Jan 1, 2024
24.28 M KRW
-48.26 B KRW
-58.78 B KRW
Jan 1, 2025
5.84 B KRW
-40.51 B KRW
-35.13 B KRW
Jan 1, 2026 (e)
63.63 B KRW
-5.05 B KRW
-41.45 B KRW

GI Innovation Margins

GI Innovation stock margins

The GI Innovation margin analysis displays the gross margin, EBIT margin, as well as the profit margin of GI Innovation. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for GI Innovation.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
100.00 %
-207.63 %
-689.25 %
Jan 1, 2021
100.00 %
-573.04 %
-2,691.82 %
Jan 1, 2022
100.00 %
-1,941.49 %
-2,280.94 %
Jan 1, 2023
100.00 %
-1,002.18 %
-1,043.37 %
Jan 1, 2024
100.00 %
-198,751.86 %
-242,096.07 %
Jan 1, 2025
100.00 %
-693.81 %
-601.82 %
Jan 1, 2026 (e)
100.00 %
-7.94 %
-65.14 %

GI Innovation Stock analysis

What does GI Innovation do? GI Innovation Inc is a biotechnology firm headquartered in Seoul, South Korea, operating within the health care sector. The company was established to focus on the research and development of innovative biopharmaceutical products, aiming to address significant unmet medical needs through advanced scientific approaches. As a relatively young entity in the industry, GI Innovation went public on March 30, 2023, marking a significant milestone in its corporate development and providing it with the necessary capital to accelerate its pipeline activities. The organization currently employs a team of 84 full-time professionals who are dedicated to advancing its drug discovery and development programs. The business model of GI Innovation is distinct in that it primarily generates revenue through license fees derived from the technology transfer of its proprietary drug candidates. This strategy allows the company to monetize its intellectual property and research findings without necessarily bearing the full cost and risk of late-stage clinical trials and commercialization for every asset. The core of the company's value proposition lies in its pipeline of new drug candidates that are currently in pre-clinical and early clinical stages. Among its most notable assets are GI-101, an immuno-oncology therapy designed to harness the body's immune system to fight cancer, and GI-301, a treatment aimed at addressing allergic conditions. These candidates represent the company's strategic focus on high-potential therapeutic areas where novel mechanisms of action can provide competitive advantages. By leveraging its expertise in biopharmaceutical development, GI Innovation seeks to establish itself as a meaningful player in the global biotechnology landscape. The company's website, https://www.gi-innovation.com/, serves as a primary resource for stakeholders seeking further information on its scientific progress and corporate updates. With its recent IPO and a focused pipeline, GI Innovation Inc is positioned to navigate the complexities of drug development while aiming to deliver impactful healthcare solutions to patients worldwide. The company's ISIN, KR7358570000, and ticker symbol, 358570.KQ, facilitate its trading on the Korean market, allowing investors to participate in its growth trajectory. GI Innovation is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing GI Innovation's EBIT

GI Innovation's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of GI Innovation's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

GI Innovation's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in GI Innovation’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about GI Innovation stock

EBIT of GI Innovation is -40.51 B KRW in 2025.

EBIT of GI Innovation changed from -48.26 B KRW to -40.51 B KRW, representing a -16.07% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT GI Innovation since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's GI Innovation historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — GI Innovation

All Key Metrics — GI Innovation